Advertisement

Can pancreatic cancer be detected by adrenomedullin in patients with new-onset diabetes? The PaCANOD cohort study protocol

Abstract

Introduction

Pancreatic cancer is a leading cause of cancer-related death. Its diagnosis is often delayed and patients are frequently found to have unresectable disease. Patients diagnosed with new-onset diabetes have an 8-fold risk of harboring pancreatic cancer. Adrenomedullin has been claimed to mediate diabetes in pancreatic cancer. New screening tools are needed to develop an early diagnosis protocol.

Methods

Patients aged 45-75 years within 2 years of first fulfilling the ADA criteria for diabetes will be prospectively enrolled in this study. Sepsis, renal failure, microangiopathy, pregnancy, acute heart failure and previous malignancies will be considered as exclusion criteria.

Results

440 patients diagnosed with new-onset diabetes will be enrolled and divided into 2 groups: one with high adrenomedullin levels and one with low adrenomedullin levels. Patients will undergo 3 years’ follow-up to detect pancreatic cancer development.

Conclusions

Identifying a marker for pancreatic cancer among high-risk patients such as new-onset diabetics might lead to the identification of a subpopulation needing to be screened in order to enable early diagnosis and treatment of a highly lethal tumor.

Trial registration

This trial was registered at ClinicalTrials.gov on May 25, 2015 under registration number NCT02456051.

Post author correction

Article Type: CLINICAL TRIAL PROTOCOL

DOI:10.5301/tj.5000693

Authors

Laura Antolino, Mara La Rocca, Federico Todde, Elena Catarinozzi, Paolo Aurello, Lucilla Bollanti, Giovanni Ramacciato, Francesco D’Angelo

Article History

Disclosures

Financial support: This study was funded by the Sapienza University of Rome, Progetti Avvio alla Ricerca, financial year 2014.
Conflict of interest: The authors have no competing interests to declare.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

Affiliations

  • General Surgery, St. Andrea University Hospital, Faculty of Medicine and Psychology, Sapienza University, Rome - Italy
  • Internal Medicine, St. Andrea University Hospital, Faculty of Medicine and Psychology, Sapienza University, Rome - Italy
  • Occupational Medicine, St. Andrea University Hospital, Faculty of Medicine and Psychology, Sapienza University, Rome - Italy
  • Endocrinology and Diabetology, St. Andrea University Hospital, Faculty of Medicine and Psychology, Sapienza University, Rome - Italy

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.